EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Design and Application of Biosafe Coronavirus Engineering Systems without Virulence

Guoqiang Wu, Qiaoyu Li, Junbiao Dai iD, Guobin Mao, Yingxin Ma

Viruses · 2024

DOI: 10.3390/v16050659 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Guoqiang Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Quantitative Engineering Biology, Guangdong Provincial Key Laboratory of Synthetic Genomics and Shenzhen Key Laboratory of Synt…. Hauptthemen laut MEDLINE: SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shenzhen Municipal Science and Technology Innovation Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the last twenty years, three deadly zoonotic coronaviruses (CoVs)—namely, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-2—have emerged. They are considered highly pathogenic for humans, particularly SARS-CoV-2, which caused the 2019 CoV disease pandemic (COVID-19), endangering the lives and health of people globally and causing unpredictable economic losses. Experiments on wild-type viruses require biosafety level 3 or 4 laboratories (BSL-3 or BSL-4), which significantly hinders basic virological research. Therefore, the development of various biosafe CoV systems without virulence is urgently needed to meet the requirements of different research fields, such as antiviral and vaccine evaluation. This review aimed to comprehensively summarize the biosafety of CoV engineering systems. These systems combine virological foundations with synthetic genomics techniques, enabling the development of efficient tools for attenuated or non-virulent vaccines, the screening of antiviral drugs, and the investigation of the pathogenic mechanisms of novel microorganisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2HumansAnimalsVirulenceContainment of BiohazardsCOVID-19Antiviral Agents

Stichwörter der Autor:innen

applicationbiosafetycoronaviruspseudovirustrans-complementation system

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • CAS Key Laboratory of Quantitative Engineering Biology, Guangdong Provincial Key Laboratory of Synthetic Genomics and Shenzhen Key Laboratory of Synthetic Genomics, Shenzhen Institute of Synthetic Biology, Shenzhen Inst…
  • School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau SAR 999078, China.
  • College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
  • Shenzhen Branch, Guangdong Laboratory for Lingnan Modern Agriculture, Key Laboratory of Synthetic Biology, Ministry of Agriculture and Rural Affairs, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agric…

ORCID-Profile: Junbiao Dai

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Shenzhen Municipal Science and Technology Innovation Council
  • Youth Innovation Promotion Association CAS
  • Guangdong Provincial Key Laboratory of Synthetic Genomics
  • Shenzhen Key Laboratory of Synthetic Genomics
  • Shenzhen Science and Technology Program
  • Shenzhen Out-standing Talents Training Fund

Zitieren

APA

Wu, G., Li, Q., Dai, J., Mao, G., & Ma, Y. (2024). Design and Application of Biosafe Coronavirus Engineering Systems without Virulence. Viruses. https://doi.org/10.3390/v16050659

Vancouver

Wu G, Li Q, Dai J, Mao G, Ma Y. Design and Application of Biosafe Coronavirus Engineering Systems without Virulence. Viruses. 2024. doi:10.3390/v16050659

BibTeX
@article{Wu2024,
  author = {Wu, Guoqiang and Li, Qiaoyu and Dai, Junbiao and Mao, Guobin and Ma, Yingxin},
  title = {Design and Application of Biosafe Coronavirus Engineering Systems without Virulence},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16050659}
}
Kostenlos starten →